Related Experiment Video
Updated: May 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
Miriam Estebanez1, Natalia Stella-Ascariz, Guillermo Ruiz-Carrascoso
1HIV Unit, Internal Medicine Service bMicrobiology Service. Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Abstract:
We report long-term virologic response to etravirine and tenofovir/emtricitabine in four HIV-1-infected patients who had prior standard genotypic resistance testing showing an isolated K103N mutation (three acquired, one transmitted). In three patients tested, the K103N mutation was detected in cellular HIV-1 DNA whereas remaining suppressed on etravirine plus tenofovir/emtricitabine.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Viral Mutations
Inhibitors of Viral Protein Synthesis
Size and Structure of Viral Genomes

